In addition, a transwell invasion assay revealed that forced expression of USP39 significantly enhanced the invasion capacity whereas knockdown of USP39 decreased the invasion potential of ovarian cancer cells (Fig. 2D). The gene discussed is USP39; the disease is ovarian cancer.